Trend CRISPR making biology programmable across agriculture, health and industry

Summary

The report imagines an increasingly programmable biology, with crops that withstand extreme drought, bacteria that capture pollutants and cells designed to correct inherited diseases. CRISPR, developed a little over a decade ago, is not the first form of genetic engineering but the one that made DNA editing possible with previously unattainable speed, precision and versatility. It works like guided molecular scissors that find a specific stretch of DNA and change it much as one corrects a letter in a text, often without introducing genes from other species, which sets it apart from many classic transgenics. Newer variants such as base editing and prime editing widen the range of possible changes further. If these capabilities keep maturing, CRISPR could become a key component of a bioeconomy in which part of production relies on organisms designed for specific tasks. That shift is already visible in drought and heat tolerant crop varieties, clinical trials for blood disorders, some cancers and hereditary diseases, and edited microbes producing biopolymers and enzymes.